Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
135.18
-0.12 (-0.09%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
3
4
5
6
7
8
9
...
58
59
Next >
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
June 28, 2024
These healthcare stocks have clear paths to growth over the next few years.
Via
The Motley Fool
Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
June 27, 2024
2seventy Bio finalized an asset purchase agreement with Novo Nordisk involving the Hemophilia A program and in vivo gene editing technology. The 2seventy bio team will join Novo Nordisk, focusing on...
Via
Benzinga
Volkswagen Puts Our Rivian Bet In The Black: The Pros And Cons Of Trading Options Versus Stocks
June 27, 2024
Novo Nordisk, Carvana, And Now Rivian
Via
Benzinga
Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
June 27, 2024
Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the world's most populous country. The competitive landscape and regulatory...
Via
Benzinga
Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
June 27, 2024
Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a single supplier with previously unreported ties to fraud and bankruptcy.
Via
Benzinga
Topics
Fraud
Supply Chain
Exposures
Legal
Supply Chain
A Closer Look at Novo Nordisk's Options Market Dynamics
June 25, 2024
Via
Benzinga
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
June 27, 2024
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent...
Via
Benzinga
Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More
June 26, 2024
Via
Benzinga
Novo Nordisk Halts Late-Stage Study Of Experimental Hypertension Drug, Takes Over $800M Impairment Charge
June 26, 2024
Novo Nordisk announced the failure of its phase 3 CLARION-CKD trial, which investigated ocedurenone for treating uncontrolled hypertension in advanced chronic kidney disease patients. The trial did not...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 26, 2024
Via
Benzinga
The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition
June 26, 2024
The next trillion dollar stocks have emerged in a few key areas that investors should understand in greater detail in order to profit.
Via
InvestorPlace
Better Growth Stock: Archer Aviation or Viking Therapeutics?
June 26, 2024
Which one of these potential disruptors is the better buy?
Via
The Motley Fool
Rivian, Lucid, Micron Technology, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
June 25, 2024
On Tuesday, U.S. stocks showed mixed results. The Dow Jones Industrial Average closed down by nearly 0.8%, finishing at 39,112.16
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
June 25, 2024
Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, raising concerns for similar weight loss drugs.
Via
Benzinga
Why Novo Nordisk Shares Are Trading Higher Tuesday
June 25, 2024
The company's weight loss drug Wegovy has been approved in China, the second most populated country that is estimated to have the world's highest number of overweight individuals, according to...
Via
Benzinga
Novo Nordisk Wins Approval For Its Weight-Loss Drug From China
June 25, 2024
China approved the sale of Novo Nordisk's Wegovy on Tuesday. The drugmaker also announced a $4.1 billion investment in the U.S. Novo Nordisk stock climbed 3.0% to an all-time high this morning.
Via
Talk Markets
European Stocks Dip As US Market Sentiment Sours
June 25, 2024
European stocks declined as U.S. market sentiment soured, with the Stoxx 600 index down 0.41% by mid-morning. Novo Nordisk shares rose 1.5% following the approval of its weight loss treatment in...
Via
Talk Markets
Why Is Regis (RGS) Stock Up 215% Today?
June 25, 2024
Regis stock is up on Tuesday with heavy trading of RGS shares after it announced a new credit facility to pay of its debts.
Via
InvestorPlace
Jefferies Just Raised Its Price Target on Nvidia (NVDA) Stock
June 25, 2024
Nvidia stock is up on Tuesday after shares of NVDA got an increased price target from Jefferies analysts alongside praise.
Via
InvestorPlace
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
June 25, 2024
This is a matchup that the latecomer might not be able to win.
Via
The Motley Fool
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
June 25, 2024
Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them.
Via
InvestorPlace
Novo Nordisk Surges Nearly 3% After Weight Loss Drug Wegovy Wins Approval in China
June 25, 2024
Novo Nordisk's weight loss drug Wegovy has received approval in China, representing a notable achievement for the Danish pharmaceutical firm.
Via
Benzinga
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
June 25, 2024
Novartis stock is in a buy range after moving past a 103.55 entry in a cup with handle. The buy range extends to 5% above the initial entry.
Via
Investor's Business Daily
Wegovy, Ozempic Maker Novo Nordisk To Invest $4.1B In US Manufacturing, Doubling Plant Size To Meet Surging Demand For Weight Loss Drugs
June 25, 2024
Novo Nordisk A/S is set to invest $4.1 billion in expanding its U.S. manufacturing operations to meet the increasing demand for its weight loss drugs.
Via
Benzinga
Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs
June 24, 2024
Regeneron Pharmaceuticals released data from a Phase 1 study on garetosmab and trevogrumab at the ADA meeting, showing significant increases in lean mass and reductions in fat mass in healthy...
Via
Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
June 24, 2024
Eli Lilly's stock may rise due to supply issues at competitor Novo Nordisk, according to Reddit users. Its weight loss drug and upcoming FDA approval are also factors. Investors are optimistic about...
Via
Benzinga
Exposures
Product Safety
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
June 24, 2024
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.
Via
InvestorPlace
7 Strong Buy Blue-Chip Stocks to Keep You in the Green
June 24, 2024
Consider these seven strong buy blue-chip stocks for steady growth of your investment portfolio, no matter the market situation.
Via
InvestorPlace
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
June 24, 2024
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.
Via
Benzinga
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.